stockrowSmith & Nephew SNATS, Inc.
SNN Healthcare Medical Devices
Smith & Nephew SNATS, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6.2 billion, up 6.09% from fiscal 2024.
Follow SNN
Alert me
Smith & Nephew SNATS, Inc. (SNN) Free cash flow
Smith & Nephew SNATS, Inc.'s free cash flow for fiscal 2025 was $890.0M, up 46.9% from $606.0M in fiscal 2024. Over the twelve months to 30 June 2026 it was $2.0B. Over the past ten years it has ranged from $110.0M (fiscal 2022) to $890.0M (fiscal 2025) — the current reading is the highest in ten years. Free cash flow has risen for 3 consecutive fiscal years. Smith & Nephew SNATS, Inc. ranks 6th of 149 Medical Devices companies by free cash flow.
Free cash flow, annual
Embed this chart
Annual newest first
| Period | Free cash flow | Change |
|---|---|---|
| FY2025 | $890.0M | 46.86% |
| FY2024 | $606.0M | 234.81% |
| FY2023 | $181.0M | 64.55% |
| FY2022 | $110.0M | (76.55%) |
| FY2021 | $469.0M | (4.67%) |
| FY2020 | $492.0M | (35.26%) |
| FY2019 | $760.0M | 30.14% |
| FY2018 | $584.0M | (18.21%) |
| FY2017 | $714.0M | 56.24% |
| FY2016 | $457.0M | (31.99%) |
Quarterly newest first
| Period | Free cash flow | Change |
|---|---|---|
| Jun 2026 | $260.0M | (70.79%) |
| Dec 2025 | $890.0M | 230.86% |
| Jun 2025 | $269.0M | (55.61%) |
| Dec 2024 | $606.0M | 818.18% |
| 18 more quarters | Free account |
Against its own ten years
Free cash flow against peers
| Company | Free cash flow |
|---|---|
| SNN Smith & Nephew SNATS, Inc. | $2.0B |
| GMED Globus Medical, Inc. compare | $766.6M |
| BIO.B Bio-Rad Laboratories, Inc. compare | $468.1M |
| BIO Bio-Rad Laboratories, Inc. compare | $468.1M |
| PODD Insulet Corporation compare | $260.0M |
| BRKR Bruker Corporation compare | $244.7M |
| PEN Penumbra, Inc. compare | $200.3M |
| TXG 10x Genomics compare | $121.4M |
| GKOS Glaukos Corporation compare | $36.0M |
What Free cash flow is
Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.
Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)
More on SNN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement